{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:39:52Z","timestamp":1789925992136,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00807-5","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T05:42:58Z","timestamp":1763530978000},"page":"327-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel LC-MS\/MS method for measuring methotrexate in high-dose therapy: a comparative study with commercial EMIT and EIA immunoassays"],"prefix":"10.1007","volume":"78","author":[{"given":"Agnieszka","family":"Czajkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Poniewierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Suchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Sierakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Pawi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Kocur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"807_CR1","doi-asserted-by":"crossref","unstructured":"Kocur A, Mikulska A, Moczulski M, Pawi\u0144ski T. Therapeutic drug monitoring of low methotrexate doses for drug exposure and adherence assessment\u2014pre-analytical variables, bioanalytical issues, and current clinical applications. Int J Mol Sci. 2024;25:13430","DOI":"10.3390\/ijms252413430"},{"key":"807_CR2","doi-asserted-by":"crossref","unstructured":"Lev\u00eaque D, Becker G, Toussaint E, Fornecker L-M, Paillard C. Clinical pharmacokinetics of methotrexate in oncology. Int J Pharmacokinet. 2017;2:137\u201347","DOI":"10.4155\/ipk-2016-0022"},{"key":"807_CR3","doi-asserted-by":"crossref","unstructured":"Mikulska A, Kocur A. Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology\u2014how should chemotherapy be conducted based on therapeutic drug monitoring? Prospect Pharm Sci. 2023;21:40\u201347","DOI":"10.56782\/pps.167"},{"key":"807_CR4","doi-asserted-by":"crossref","unstructured":"Bielack SS, Soussain C, Fox CP, Houillier C, Murciano T, Osborne W, et al. A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment. J Cancer Res Clin Oncol. 2024;150:441","DOI":"10.1007\/s00432-024-05945-6"},{"key":"807_CR5","doi-asserted-by":"crossref","unstructured":"Song Z, Hu Y, Liu S, Wang G, Zhai S, Zhang X, et al. Medication therapy of high-dose methotrexate: an evidence-based practice guideline of the Division of Therapeutic Drug monitoring, Chinese pharmacological society. Br J Clin Pharmacol. 2022;88:2456\u201372","DOI":"10.1111\/bcp.15134"},{"key":"807_CR6","unstructured":"ARK Diagnostics, Inc. Ark\u2122 methotrexate assay: instructions for use, revision 07. 2017. Available online: https:\/\/www.ark-tdm.com\/products\/cancer\/methotrexate\/pdfs\/ARK_Methotrexate_Assay_Rev07_August_2017.pdf. Accessed 5 Jul 2025. Fremont (CA): ARK Diagnostics"},{"key":"807_CR7","unstructured":"ARK Diagnostics, Inc. Ark\u2122 methotrexate ii assay: instructions for use, web revision. Fremont (CA): ARK Diagnostics; 2027. [cited 2025 Jul 5]. Available online: https:\/\/ark-tdm.com\/products\/cancer\/methotrexate-II\/pdfs\/1600-1222-00_ARK_Methotrexate_II_Assay_Web_Rev02.pdf"},{"key":"807_CR8","unstructured":"Siemens Healthcare Diagnostics, Inc. Emit\u00ae methotrexate assay for the Syva\u00ae Lab system: instructions for use. 2011. Available online: https:\/\/doclib.siemens-healthineers.com\/rest\/v1\/view?document-id=678727. Accessed 5 Jul 2025. Malvern (PA): Siemens Healthcare Diagnostics"},{"key":"807_CR9","unstructured":"European Medicines Agency. Ich guideline M10 on bioanalytical method validation. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf. Accessed 5 Jul 2025"},{"key":"807_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","volume":"38","author":"C Seger","year":"2016","unstructured":"Seger C, Shipkova M, Christians U, Billaud EM, Wang P, Holt DW, et al. Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice. Ther Drug Monit. 2016;38:170\u201389","journal-title":"Ther Drug Monit"},{"key":"807_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","volume":"38","author":"PJ Taylor","year":"2005","unstructured":"Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005;38:328\u201334","journal-title":"Clin Biochem"},{"key":"807_CR12","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS. Anal Chem. 2003;75:3019\u201330","journal-title":"Anal Chem"},{"key":"807_CR13","first-page":"709","volume":"21","author":"H Passing","year":"1983","unstructured":"Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem. 1983;21:709\u201320","journal-title":"J Clin Chem Clin Biochem"},{"key":"807_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310","journal-title":"Lancet"},{"key":"807_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1515\/cclm-2015-0578","volume":"54","author":"V G\u00fcnther","year":"2016","unstructured":"G\u00fcnther V, Mueller D, von Eckardstein A, Saleh L. Head-to-head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography mass spectrometry and the former fluorescence polarization immunoassay. Clin Chem Lab Med. 2016;54:823\u201331","journal-title":"Clin Chem Lab Med"},{"key":"807_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0042-1760668","volume":"15","author":"NK Tripathy","year":"2023","unstructured":"Tripathy NK, Mishra SK, Nathan G, Srivastava S, Gupta A, Lingaiah R. A rapid method for determination of serum methotrexate using ultra-high performance liquid chromatography\u2013tandem mass spectrometry and its application in therapeutic drug monitoring. J Lab Physicians. 2023;15:344\u201353","journal-title":"J Lab Physicians"},{"key":"807_CR17","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.2147\/DDDT.S335122","volume":"15","author":"Z Feng","year":"2021","unstructured":"Feng Z, Gao J, Gao X, Hua L, Nie X, Sun Y, et al. A validated HPLC-MS\/MS method for quantification of methotrexate and application for therapeutic drug monitoring in children and adults with non-Hodgkin lymphoma. Drug Des Devel Ther. 2021;15:4575\u201383","journal-title":"Drug Des Devel Ther"},{"key":"807_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/1078155220983407","volume":"28","author":"J Descoeur","year":"2022","unstructured":"Descoeur J, Dupuy A-M, Bargnoux A-S, Cristol J-P, Mathieu O. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate. J Oncol Pharm Pract. 2022;28:55\u201363","journal-title":"J Oncol Pharm Pract"},{"key":"807_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/bmc.3408","volume":"29","author":"D Wu","year":"2015","unstructured":"Wu D, Wang Y, Sun Y, Ouyang N, Qian J. A simple, rapid and reliable liquid chromatography\u2013mass spectrometry method for determination of methotrexate in human plasma and its application to therapeutic drug monitoring. Biomed Chromatogr. 2015;29:1197\u2013202","journal-title":"Biomed Chromatogr"},{"key":"807_CR20","first-page":"e34025","volume":"15","author":"S Nayak","year":"2023","unstructured":"Nayak S, Patel S, Nanda R, Shah SK, Mohapatra E, et al. Processing validation metrics of syva emit methotrexate assay for Beckman Coulter system. Cureus. 2023;15:e34025","journal-title":"Cureus"},{"key":"807_CR21","doi-asserted-by":"crossref","unstructured":"Chavan P, Bhat V, Karmore A, Mohite R, Waykar S, Kadu H. Establishing Syva methotrexate assay on Siemens dimension RxL analyzer: experience in a tertiary cancer care laboratory. J Lab Physicians. 2017;9:67\u201368","DOI":"10.4103\/0974-2727.187923"},{"key":"807_CR22","doi-asserted-by":"publisher","first-page":"e30831","DOI":"10.1002\/pbc.30831","volume":"71","author":"D Kibby","year":"2024","unstructured":"Kibby D, Trinkman H. Methotrexate level discrepancy post glucarpidase: a pediatric case series and review of literature. Pediatr Blood Cancer. 2024;71:e30831","journal-title":"Pediatr Blood Cancer"},{"key":"807_CR23","doi-asserted-by":"crossref","unstructured":"Bouqui\u00e9 R, Deslandes G, Nieto Bern\u00e1ldez B, Renaud C, Dailly E, Jolliet P. A fast LC-MS\/MS assay for methotrexate monitoring: validation, comparison to FPIA and application in carboxypeptidase therapy. Anal Methods. 2014;6:178\u201386","DOI":"10.1039\/C3AY40815A"},{"key":"807_CR24","doi-asserted-by":"crossref","unstructured":"Bouqui\u00e9 R, Gr\u00e9goire M, Hernando H, Azoulay C, Dailly E, Monteil-Gani\u00e8re C, et al. Evaluation of a methotrexate chemiluminescent microparticle immunoassay: comparison to fluorescence polarization immunoassay and LC-MS\/MS. Am J Clin Pathol. 2016;146:119\u201324","DOI":"10.1093\/ajcp\/aqw088"},{"key":"807_CR25","doi-asserted-by":"crossref","unstructured":"Hayashi H, Fujimaki C, Tsuboi S, Matsuyama T, Daimon T, Itoh K. Application of fluorescence polarization immunoassay for determination of methotrexate polyglutamates in rheumatoid arthritis patients. Tohoku J Exp Med. 2008;215:95\u2013101","DOI":"10.1620\/tjem.215.95"},{"key":"807_CR26","doi-asserted-by":"crossref","unstructured":"Opitz P, Fobker M, Fabian J, Hempel G. Development and validation of a bioanalytical method for quantification of methotrexate from serum and capillary blood using VAMS and online spe LC-MS. J Chromatogr A. 2024;1715:464610","DOI":"10.1016\/j.chroma.2023.464610"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00807-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:02:30Z","timestamp":1768341750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00807-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7529927\/v1","asserted-by":"object"}]},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The presented study presented results of routine diagnostic testing for methotrexate in patients treated at the Children\u2019s Memorial Institute in Warsaw, Poland. Approval reference number: 2377\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study as routine diagnostic process of MTX measurements in the Children\u2019s Memorial Health Institute in Warsaw, Poland.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}